Trutam-Plus Tab-in-Cap

Tamsulosin HCl 0.4 mg + Deflazacort 30 mg — Tablet-in-Capsule Technology

Trutam-Plus Tab-in-Cap — Tamsulosin HCl 0.4 mg + Deflazacort 30 mg (Tablet-in-Capsule) from Trumac Healthcare PCD Pharma Franchise India

Composition Tamsulosin HCl 0.4 mg + Deflazacort 30 mg (Tablet-in-Capsule)
Dosage Form Tab-in-Cap
Pack Type Alu-Alu Blister
Pack Size 10 x 10 Capsules
MRP ₹ 6900
Therapy Urology — Alpha-1A blocker + corticosteroid combination
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Trutam-Plus Tab-in-Cap

Trutam-Plus is a novel tablet-in-capsule technology delivering Tamsulosin HCl 0.4 mg (modified-release tablet) along with Deflazacort 30 mg inside a single capsule shell. The combination supports medical expulsive therapy of lower-ureteric stones with inflammatory oedema.

Tamsulosin relaxes the smooth muscle of the distal ureter, bladder neck and prostatic urethra; Deflazacort, an oxazoline derivative of prednisolone, reduces local ureteric inflammatory oedema that obstructs stone passage.

Trumac Healthcare manufactures Trutam-Plus under WHO-GMP conditions for PCD pharma franchise across India.

Indications

  • Medical expulsive therapy for lower-ureteric stones (5–10 mm) with mucosal oedema
  • Symptomatic relief in benign prostatic hyperplasia with inflammatory component
  • Post-stenting ureteric symptoms (specialist use)

Mechanism of Action

Tamsulosin selectively blocks alpha-1A adrenoceptors which dominate in the prostate, bladder neck and distal ureter — relaxing smooth muscle and easing voiding. Deflazacort is a glucocorticoid prodrug converted to its active 21-OH metabolite; it suppresses phospholipase A2, reducing prostaglandin and leukotriene production and shrinking oedema around the impacted stone — improving stone passage rates in MET.

Dosage & Administration

['Adults: 1 capsule once daily, 30 minutes after the same meal each day', 'Continue for 4 weeks or until stone expulsion', 'Swallow whole — do not crush or chew', 'Use under urologist supervision']

Side Effects

['Postural hypotension and dizziness', 'Ejaculatory dysfunction', 'Fluid retention', 'Increased appetite', 'Mood changes (with steroid component)', 'Hyperglycaemia in diabetics']

Contraindications & Precautions

['Hypersensitivity to tamsulosin or deflazacort', 'History of orthostatic hypotension', 'Severe hepatic impairment', 'Untreated active infection', 'Live vaccines during treatment']

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Trutam-Plus Tab-in-Cap is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.